Mass spectrometric characterization of the crustacean neuropeptidome  by Yu, Qing et al.
e u p a o p e n p r o t e o m i c s 3 ( 2 0 1 4 ) 152–170
Available  online  at  www.sciencedirect.com
ScienceDirect
jou rn al hom epage : ht tp : / /www.e lsev ier .com/ locate /euprot
Mass  spectrometric  characterization  of  the
crustacean neuropeptidome
Qing Yu, Chuanzi OuYang, Zhidan Liang, Lingjun Li ∗
School of Pharmacy and Department of Chemistry, University of Wisconsin – Madison, Madison, WI,  USA
a  r  t  i  c  l  e  i  n  f  o
Article history:
Available online 12 March 2014
Keywords:
Neuropeptide
NP
a  b  s  t  r  a  c  t
Neuropeptides (NPs) are the largest class of signaling molecules used by nervous systems.
Despite their functional importance, numerous challenges exist to characterize the full
complement of NPs – the neuropeptidome. In this review, we  discuss recent advances in
MS-based techniques for NP identiﬁcation and quantitation, as well as sample preparation
strategies for various applications in several crustacean model organisms. By surveying
published examples of crustacean neuropeptidomic analyses, we highlight challenges andPeptidomics
Mass spectrometry
Crustacean
progress in this dynamic ﬁeld, and summarize the current state of knowledge about crus-
tacean NPs and MS-based methodologies for NP analysis.
© 2014 Published by Elsevier B.V. on behalf of European Proteomics Association (EuPA).
This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
ﬁcation of new peptide families, signiﬁcantly expanding the1.  Introduction
Animal behaviors are precisely controlled by the nervous
system which employs a myriad of signaling molecules to
mediate this control process. One of the most diverse signaling
molecules are neuropeptides (NPs), which are synthesized as
larger precursor proteins, and undergo extensive processing
and modiﬁcation to become bioactive NPs to participate in
cell–cell signaling. Since they are directly involved in mod-
ulating many  physiological processes, such as feeding, pain
sensing and reproduction [1,2], there is growing interest in
studying their structures, functions and distributions. Because
of the relatively simple nervous system and accessible electro-
physiology at the single-cell and neural circuit level, decapod
crustacean has long been used as an attractive model prepara-
tion for neuromodulation and NP research [3,4], as evidenced
by the large number of NPs discovered since 2000 (Table 1).
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CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3Traditional studies on NPs often use biochemical techniques
that can be imprecise and cumbersome. Mass spectrome-
try (MS) has evolved as a powerful tool to characterize NPs,
due to its capability to precisely determine the identity and
primary structure of a NP as well as its ability to quantify
these signaling molecules in a complex mixture. A new con-
cept, peptidomics, was introduced in 2001, largely due to the
rapid growth of MS-based large-scale peptide and protein
analysis [5–7]. By exploring the utility of MS  based methods,
various NP families with multiple isoforms that differ from
each other by a single amino acid can be distinguished in
contrast to antibody-based immunochemical techniques. The
combined use of MS and MS/MS  scans enable the discovery
of novel members of established NP families and the identi-mistry, University of Wisconsin – Madison, 777 Highland Avenue,
 262 5345.
neuropeptidome in a model organism [3,8]. With their struc-
tural information available, the next step for NP study is to
determine its function during various physiological processes.
omics Association (EuPA). This is an open access article under the
.0/).
e u  p a o p e n p r o t e o m i c s 3 ( 2 0 1 4 ) 152–170 153
Table 1 – Crustacean neuropeptidomic studies by mass spectrometric techniques.
Species Tissues studied MS instrumentation References
Ghost crab Ocypode
ceratophthalma
Eyestalk ganglia (including
sinus glands), brain,
pericardial organ
MALDI-TOF/TOF
ESI-Q-TOF
[32]
Jonah crab Cancer borealis Hemolymph,
stomatogastric nervous
system, pericardial organ,
thoracic ganglia
MALDI-TOF/TOF
ESI-Q-TOF
MALDI–FTMS
[39,45,91,104,115,187]
American lobster Homarus
americanus
Brain, pericardial organ,
stomatogastric ganglion
MALDI–FTMS
ESI-Q-TOF
MALDI TOF/TOF
MALDI LTQ Orbitrap
[36,37,40,89,135,188]
Blue crab Callinectes sapidus Pericardial organ,
stomatogastric nervous
system, sinus gland
MALDI–FTICR
ESI-Q-TOF
MALDI TOF/TOF
[42,46]
Water ﬂea Daphnia pulex Brain-optic ganglia, brain MALDI TOF/TOF [189]
White shrimp Litopenaeus
vannamei
Sinus gland, brain MALDI-FTMS
ESI-Q-TOF
[44]
European green crab
Carcinus maenas
Brain,  thoracic ganglia,
sinus gland, pericardial
organ
MALDI-FTMS
ESI-Q-TOF
[116]
Spinycheek crayﬁsh
Orconectes limosus
Sinus gland ESI-Q-TOF [38]
Red swamp crayﬁsh
Procambarus clarkii
Brains, ventral nerve cord ESI-Q-TOF
MALDI TOF/TOF
[135,190]
Giant tiger prawn Penaeus
monodon
Eyestalk, brain, thoracic
ganglia
ESI-Q-TOF [191–194]
Common yabby Cherax
destructor
Stomatogastric nervous
system
MALDI TOF/TOF [195]
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he advancement of MS-based tools and tandem MS  capa-
ility coupled with isotope labeling strategies and label-free
pproaches have accelerated several large-scale comparative
europeptidomic analyses, enabling a global view of coordi-
ated changes of NPs related to a physiological process.
.  Sample  preparation
.1.  Overview  of  sampling  strategies
ecause of the biochemical complexity, high-salt contents,
nd endogenous proteases, sample preparation is often
ritical to produce the desired outcome of a peptidomic exper-
ment. Depending on the goals and requirements of speciﬁc
xperiments, various sample preparation methods have been
eveloped. As outlined in Fig. 1, samples can be prepared by
omogenization and extraction of tissues, analyzed by direct
issue experiments or collected by microdialysis techniques
ollowed by liquid chromatography (LC) coupled to MS  or
S/MS  analysis.
.2.  Sample  preparation  for  direct  tissue  analysis
or tissue-based study, it is crucial to avoid delocalization
nd degradation of analytes. Proper tissue harvest, stabi-
ization and preservation are all important aspects in the
ample preparation process. After animal sacriﬁce, snap-
reezing dissected tissue in powdered dry ice, liquid nitrogenMALDI-FTMS
ESI-Q-TOF
[196]
or liquid nitrogen-chilled isopentane would quickly preserve
the structural integrity. Storage at −80 ◦C is required to min-
imize the degradation until use [9]. Longer freezing method
could be achieved by loosely wrapping the tissue in aluminum
foil and gently placing it into liquid nitrogen, ice-cold ethanol
or isopropanol bath for 30–60 s [10].
Tissue preservation is required to prevent post mortem
proteome degradation and slow down sample aging before
actual MS experiments. Common methods include focus-
ing microwave irradiation [11] and thermal denaturation
by Stabilizor T1, which extensively denature active pro-
teolytic enzymes [12,13]. Other popular method such as
formaldehyde-ﬁxed parafﬁn-embedding (FFPE) is not very
suitable with MS imaging because of the cross-linking it
caused between peptides and proteins [14]. A modiﬁed
approach of formalin-ﬁxed parafﬁn embedding used ethanol
rather than formalin to ﬁx the tissue. MS images generated in
this way were signiﬁcantly improved [15].
One signiﬁcant advantage of direct tissue analysis over
liquid phase LC–MS method is the ability to preserve the
structural integrity and morphology of the tissue. In order
to get smooth thin tissue sections around 10–20 m in cryo-
stat, tissues are usually embedded in supporting media such
as optimal cutting temperature (OCT) compound, Tissue-
tek and carboxymethylcellulose (CMC) [10]. However, these
polymer-based materials which contain polyethylene glycol
(PEG), polyvinyl alcohol (PVA), or both, can cause strong back-
ground signals which mask the detection of peptides and
proteins of interest. In order to eliminate the interference from
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Fig. 1 – Illustration of four major sample preparation strategies for mass spectrometric analysis of neuropeptides: (1) direct
imaging of tissue sections, (2) direct proﬁling of isolated tissues, (3) analysis of tissue extract, and (4) in vivo microdialysis
sampling.
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mbedding materials, ice is commonly used for analytes at
ow m/z  [16]. At medium and high mass range, gelatin is able
o provide high-quality MS  images with minimal interference
17,18]. Sucrose is also a promising alternative as reported by
erhaert et al. in their study of the NPs in a cockroach brain
19]. Strohalm et al. were able to use poly[N-(2-hydroxypropyl)
ethacrylamide] (pHPMA) as a novel embedding/supporting
aterial to enhance the signal intensity from bumblebee and
ouse lung samples without visible background peaks [20].
Fixation of tissue slices onto sample plate is commonly
chieved by thaw-mounting [10]. When the analysis is carried
ut on a matrix-assisted laser desorption/ionization (MALDI)
OF instrument, an electrically conductive sample plate is
equired, such as gold-coated, ITO-coated glass slides or stain-
ess steel metal plates [21,22]. For MALDI linear ion trap (LIT)
ased mass spectrometric study, regular microscopic glass
lides work as well [19]. Transparent glass slides also allow
istological tissue staining after mass spectrometric imaging
MSI) studies to enable the correlation on the same tissue
ection. When reversible matrix-wash-up step is required
or subsequent study, such as histological staining, adhe-
ive double-sided conductive tape is preferred as the ﬁxative
pproach.
When the interest of study is peptides and proteins in MSI,
ashing the ﬁxed tissue before matrix deposition is often car-
ied out to remove salts and lipids. When the composition of
rganic washing solution is optimized for speciﬁc tissue sam-
le, the acquired MS  spectra show enhanced signal and ion
ields [23]. Commonly used washing solution contains differ-
nt combinations of methanol, ethanol, acetone, hexane and
hloroform [24,25]. It is important to point out that the com-
osition of the washing solution and the washing protocol is
rucial to the success of the following MSI  investigation. Sub-
ptimal washing solutions could cause hydrophilic peptides
nd low abundance analytes to be washed off. Inappropriate
ashing procedure could lead to delocalization of protein and
eptides on tissue surface.
After the tissue section is prepared, one could do either tis-
ue proﬁling or tissue imaging to acquire MS information from
he sample. To intentionally and quickly make comparisons
etween and among distinct areas on tissue without precise
patial information, tissue proﬁling is usually preferred. This
pproach normally samples 5–20 discrete spots on the tissue
o give representative MS  spectra in each area [26]. For bet-
er statistical conﬁdence, the number of acquisitions needs
o be adjusted for speciﬁc studies. Under longer experimental
ime, tissue imaging approach obtains complete chemical and
patial information over the entire tissue with higher resolu-
ion. Depending on the deﬁnition of raster step-size in speciﬁc
xperiment, one tissue section is divided into a number of
rderly aligned pixel fractions. The instrument samples each
raction and generates MS  data with corresponding location
nformation. By combining the results from all the fractions,
eptides and proteins of interest could be plotted over the
 and y axes on the 2D tissue map  to show the localization
attern.A matrix with the ability to absorb and transfer laser
nergy is required in MALDI MS  to trigger desorption and
onization of the analyte. For NP analysis, common matri-
es include -cyano-4-hydroxy-cinnamic acid (CHCA) and ( 2 0 1 4 ) 152–170 155
2,5-dihydroxybenzoic acid (DHB). Peptides and proteins are
extracted from thin tissue sections while matrix is deposited
onto the tissue surface. The composition of solvents in
the matrix solution needs to be optimized for the best
extraction efﬁciency. To preserve the localization informa-
tion of analyte on the tissue surface, two matrix application
methods are common: microspotting and spray coating [27].
Several well-developed techniques are available to produce
homogenous thin layer deposition for high resolution MSI
experiments. Airbrush, TM sprayer and thin layer chromatog-
raphy sprayer are pneumatic-spray-based, while ImagePrep
from Bruker Daltonics is vibrational-spray-based. Others like
acoustic, piezoelectric, ink-jet printer, capillary-deposition
and mist-nebulizing spray coating techniques are robotic
and commercially available. Size of the matrix solution
droplet could be adjusted in most of the above approaches.
Smaller droplet size results in ﬁner spatial resolution however
decrease the extraction efﬁciency and sensitivity of detection.
Spectral quality and reproducibility is improved when matrix
solution is densely spotted in arrays with the tradeoff of lower
spatial resolution.
When migration and diffusion of the analytes become a
major concern for speciﬁc tissue samples, dry matrix appli-
cation could minimize the disadvantages. However, because
of the lack of efﬁcient extraction and cocrystallization-
interaction between analytes and matrix, the sensitivity of
these approaches is somewhat limited [28–30].
2.3.  Tissue  extraction  analysis
Many  neuropeptidomic analyses employ tissue homogeniza-
tion followed by extraction method. In this approach, speciﬁc
tissues from multiple animals are often pooled and homog-
enized, followed by extraction with acidic buffer and then
further separated or fractionated. The resulting extract is
then analyzed by MS,  generally either online or ofﬂine
with electrospray ionization (ESI) type of instruments, and
sometimes MALDI instruments. Advantages of this approach
are the feasibility with any organism regardless of the
tissue size. With pooling method, signiﬁcant amounts of
NPs can be extracted followed by LC–MS/MS for identiﬁca-
tions, which is suitable for MS  instruments with modest
sensitivity.
Homogenization and extraction are performed in the pres-
ence of solvent buffers which can deactivate proteases from
degrading proteins and peptides in the sample. Acidiﬁed
methanol [31,32] is most commonly used in studying crus-
tacean NPs, with other examples being acidiﬁed acetone
[33,34], a combination of acidiﬁed methanol spiked with EDTA
and protease inhibitors [35]. Following the homogenization
and extraction, centrifugation is typically performed to elim-
inate cell debris. The supernatant is then concentrated and,
if necessary, a C18 desalting protocol can be applied. In
many  cases, reversed-phase liquid chromatography (RPLC) is
adapted to fractionate complex crustacean NP mixtures as to
increase neuropeptidome coverage by enabling detections of
low abundance NPs [36–38].
This strategy has been successfully used to characterize
NPs in many  crustacean species [32,36,37,39–45]. In addition,
two-dimensional reversed-phase liquid chromatography (2D
 m i c s156  e u  p a o p e n p r o t e o
RP-LC) has been used by Hui et al. to characterize the neu-
ropeptidome of the pericardial organ in blue crab Callinectes
sapidus [46]. Alternative multidimensional chromatographic
separation, which employs strong cation-exchange (SCX)
chromatography followed by reversed phase liquid chro-
matography (RPLC) has been developed and used in studying
peptides and proteins in other organisms, such as Caenorbabdi-
tis elegans and Rattus norvegicus [47,48]. Most recently, another
integration of two chromatographic techniques, hydrophilic
interaction liquid chromatography (HILIC) and RPLC, was
introduced as a promising addition [49,50]. Another approach
to enrich NP content in samples is immuno-based methodol-
ogy. For example, speciﬁc antibodies that recognize consensus
sequence in a peptide family can enrich the target NP family
from complex sample background [45,51].
2.4.  Microdialysis
Tissue-based sample preparation coupled with mass spectro-
metric analysis could provide important information about
peptide sequence and post-translational modiﬁcations (PTM)
[46,52]. However, several disadvantages also exist, including
the inability to determine whether a peptide is secreted and
the high complexity of extract associated with tissue homog-
enization [53].
In contrast to tissue-based NP sampling technique, ﬂuid-
based method samples NPs from stimuli evoked neuronal
releasate [54–57], blood or hemolymph [35,58–60]. Signaling
molecules could be collected from such media, and detected to
conﬁrm its presence. It allows direct analysis of signaling neu-
romodulators under physiological condition manipulations
and has the ability to distinguish biologically active molecules
from NP precursor processing intermediates. Marder and
co-workers [56] were able to detect electrically stimulated
neuronal release of NPs from the allatostatin and tachykinin-
related peptide families from the stomatogastric nervous
system of Jonah crab, Cancer borealis. Recently, Zhong et al. [57]
reported a quantitative measurement of peptide content in
cell releasate in a microﬂuidic device with MALDI mass spec-
trometry. Despite the requirement for sophisticated sample
handling, technical difﬁculties, including very small volume
of releasate (L level), NP degradation due to the presence of
peptidases, become the major issue for wide application of
such techniques.
Hemolymph sampling is often achieved by using a nee-
dle attached to a syringe and withdrawing certain amount
of bioﬂuid from the animal followed by NP extraction and
clean-up steps. Kwok and co-workers [61] extracted and
identiﬁed allatostatin-like peptides from freshwater crayﬁsh,
Procambarus clarkii.  We were able to identify members of sev-
eral NP families, such as RFamide, allatostatin, orcokinin,
tachykinin-related peptides and crustacean cardioactive pep-
tide from the hemolymph of Cancer borealis with MALDI MS
[35]. Recently, novel members of oxytocin/vasopressin-related
peptides have been detected in the cuttleﬁsh, Sepia ofﬁni-
nalis, by Henry et al. [62] The presence of abundant proteins
in hemolymph, however, could suppress the identiﬁcation
of trace level NPs. Protein degradation products are believed
to exist in hemolymph as nicely summarized by Fredrick
and Ravichandran [63]. Moreover, the needle sampling 3 ( 2 0 1 4 ) 152–170
process could be disturbing to the animal, and cause arti-
ﬁcial release of NPs which would result in misleading
results.
The limitations imposed by these methods could be over-
come by employing alternative sample preparation strategies.
Several sampling techniques offer the capability to collect
analytes from the extracellular space, thus enable monitor-
ing the release and dynamic changes of substances in vivo
upon a deﬁned behavior or stimuli of interest. Characterizing
the concentration changes of such compounds would provide
valuable insights into their potential functional role. Push–pull
perfusion and microdialysis (MD) are two most commonly
used in vivo sampling techniques.
In the push–pull perfusion sampling process, two concen-
tric tubes were applied while pushing liquid through one tube
and pulling out sample from the other one [64,65]. It could
provide a better recovery rate as a result of faster infusion ﬂow
rate compared to MD. However, the infusion tube is directly
exposed to the tissue, so one of the major downsides of this
technique is potential tissue damage. Shippy and co-workers
[66] had worked to minimize the tissue damage problem by
operating it at very low ﬂow rates (10–50 nL/min), but longer
duration is necessary to collect enough sample to be detected.
This has become a more  serious concern when it comes to
NPs, with the estimated concentration in circulation at the
pM to nM level [67]. A longer sampling time would affect the
temporal resolution.
MD is preferred over push–pull perfusion in the past few
decades, which has been well established to measure a wide
range of substances in vivo, from low-mass-substances such
as electrolytes [68], amines and amino acids [69] to larger
molecules such as NPs [39,70]. MD sampling was well estab-
lished to collect samples from almost any human tissue
but it has also been successfully applied in invertebrates,
such as from the pericardial region of crustaceans [39]. Since
ﬁrst reported by Bito et al. [71] in 1966, MD  has extended
its applications in both the pharmacology and neuroscience
ﬁelds.
To perform MD sampling, a dialysis probe is implanted into
the tissue area of interest. Perfusing liquid is pumping at a
steady rate of 0.1–10 L/min through the inlet and bioﬂuid
is collected from the outlet at the same time. MD sampling
is based on passive diffusion, so it has minimal disturbance
to the animal. The animal is alert and freely moving, which
allows for long-term study [72] and the animal serves as
its own control. There are several different kinds of probes
designed to sample ﬂuids from different tissue types, but
they all follow similar principle [73]. The tip of the MD probe
has a pre-deﬁned molecular weight cut-off pore size which
only allows molecules smaller than that to be diffused into
the probe and collected according to concentration gradient.
This offers a cleaner sample to work with compared to tis-
sue extraction since large molecules such as proteins could be
excluded. This feature beneﬁts the study of neurotransmit-
ters by real-time monitoring of the dynamic changes during
behavior or upon stimulation.Circulating peptide hormones are present at extremely
low concentrations, pM to nM, in extracellular space as indi-
cated in other studies [60], and low recovery rate made the
analysis of NP content in dialysis very challenging. High
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ensitivity detection methods, which handle L volumes, are
sually coupled with MD  sampling. Immunoassays, usually
adioimmunoassays (RIA), were used to measure NP release
ollected from MD  [74], but it has limited speciﬁcity due to
ross reactivity, which is not suitable for complex sample anal-
sis and novel peptide discovery. Mass spectrometry offers an
ttractive tool to be coupled with MD  to detect NPs at pM or
ven lower concentrations [39,75], and it enables simultaneous
dentiﬁcation and quantitation.
The recovery rate is calculated by dividing the concen-
ration of the substance collected in the probe over its
oncentration in the extracellular space. According to in vitro
xperiments, MD  recovery rate for NPs is at 20–30% [70]. There
re several factors that could affect the recovery rate such
s molecular size and ﬂow rate, which could be manipu-
ated to improve the recovery rate. Signiﬁcant improvement
n recovery rate has been achieved for amines and drugs
sing ultraslow ﬂow rate [76,77]. However, improving recov-
ry could be challenging for larger molecules, like NPs. Roy
nd co-workers [78] have constructed a microdialysis probe
sing material with a larger pore size (molecular weight cut-
ff 50 kDa and 100 kDa) to get better recovery. But it is more
uitable for sampling proteins instead of NPs whose mass
ange is around 500–10 kDa [79–83]. Afﬁnity-enhanced MD,
here an afﬁnity agent is added into the perfusing liquid
o increase the recovery rate, has been applied in a wide
ange of studies [70,81,84,85], including a recent study from
ur group using RFamide antibody linked magnetic nanoparti-
les as afﬁnity agents to enhance recovery of RFamide-related
eptides in microdialysate from Jonah crab, Cancer borealis
75].
Temporal resolution is deﬁned as the shortest time dura-
ion over which a dynamic change event can be observed.
igh temporal resolution could be achieved by MD, which is
ritical for the functional study targeted compounds. To be
ble to accurately correlate the concentration of analytes with
ehavior or stimuli, the analysis time must be shorter than
he duration of measured events. Working with high sensitiv-
ty analysis assay, temporal resolution is deﬁned by ﬂow rate
nd detection limit. If the ﬂow rate is 1 L/min, and the ana-
yte concentration in the perfusate is around M, then a few
inutes or even seconds of sampling duration interval can be
eached with LC–MS coupling to MD [86–88].
.  Structural  elucidation
he structures of NPs were previously determined by the
ombination of chromatographic separation and Edman
egradation, which would require a large amount of pure
ample and is very time-consuming. However, MS-based tech-
iques enable high throughput acquisition of NP fragment
nformation. Even without available genome information,
ass spectrometry can still be used to proﬁle and characterize
he neuropeptidome of a speciﬁc organism..1.  Characterization  of  the  neuropeptidome
ith its multifaceted capabilities, mass spectrometry has
reatly shifted discovery of NPs from the identiﬁcation of a ( 2 0 1 4 ) 152–170 157
single peptide to the characterization of the entire peptidome.
MALDI-based mass spectrometers feature high sensitivity, tol-
erance to contaminants and convenient sample preparations.
The ability to do in situ sequencing of NPs, mapping the spa-
tial distribution and localization offers unique advantages
compared to other MS  techniques and has enabled characteri-
zation of NP sequences and distributions [89–91]. Preference to
generate singly charged ions in MALDI-MS simpliﬁes spectra
interpretation [92]. MALDI MS also enables detection of some
NPs that otherwise could be missed in ESI quadrupole time-
of-ﬂight (Q-TOF) mass spectrometry because of sample loss or
dilution during LC separations. ESI interfaced mass spectro-
meters, on the other hand, are advantageous in that they can
produce multiply charged ions, effectively extending the mass
range of the analyzer to accommodate proteins and peptides
with masses up to MDa. ESI-based MS platforms work well
with pooled samples and upstream online LC separation. Due
to the reduced sample complexity, multiple charging effects
and resulting efﬁcient fragmentation, the ESI source in gen-
eral offers greater coverage of the peptidome. ESI is a soft
ionization process so that intact molecular ions are observed.
Thermally labile bio-molecules or some non-covalent interac-
tions that are not amenable to traditional ionization methods
could be well preserved in ESI [93,94].
While it is feasible to predict peptide sequences from
a genome sequence and match with accurate mass, frag-
mentation of multiply charged ions yields more  detectable
fragment ions [95]. Fragmentation ﬁngerprints are especially
necessary when working with crustaceans as little genomic
information is known about these organisms. Traditionally,
collision-induced dissociation (CID) is employed for fragmen-
tation. Upon collision with neutral gas molecules, increased
vibrational energy redistributes over the peptide. Fragmenta-
tion ideally occurs along the backbone amide bond leading to
the formation of b- and y-type daughter ions.
The CID process is highly effective, or somewhat biased, for
small (∼20 amino acid residues), low-charged peptides (∼+3).
Additionally the fragmentation efﬁciency highly depends on
mobile protons, yet the presence of several basic amino acids
in the sequence can prevent the random protonation and
therefore produce more  site speciﬁc fragments rather than
sequence-speciﬁc fragment ions covering the whole sequence
[96]. Another drawback of CID is that several PTMs, such as
phosphorylation and glycosylation, are labile to collisions and
thus result in incomplete or even wrong sequence assignment.
Higher-energy collision dissociation (HCD) [97] and electron
transfer dissociation (ETD) [98] serve as two  alternatives to CID
to solve these problems. HCD employs higher energy dissocia-
tions than those used in ion trap CID, enabling a wider range of
fragmentation pattern including the low-mass region diagnos-
tic immonium ions. ETD induces fragmentation of cations by
transferring electrons to them via an anion reagent. In contrast
to CID, ETD can preserve labile PTMs, and has no preferred
cleavage sites except for resistance to cleavage at proline,
which leads to a more  uniform fragment ions following a lower
energy pathway and it outperforms CID in fragmenting higher
charged parent ions [99] which will be discussed below. ETD
generates a different set of fragment ions, that is c- and z-ions
[100–102] compared to CID and HCD which generate b- and
y-ions.
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Strategies combining multiple mass spectral platforms,
including MALDI-TOF/TOF-MS, MALDI-FTMS and nanoLC-ESI-
Q-TOF MS/MS,  were used to study the neuropeptidome of
crustaceans [39,40,44–46,103–105]. Since peptides have vary-
ing numbers of amino acids and these fragmentationt modes
work best for different size of peptides, an emerging technique
combines the orthogonal data by alternating between CID and
ETD (and sometimes HCD) for acquisition of multiple MS/MS
spectra from each peptide [106]. This alternate mode shows
great potential to provide extensive peptide sequence infor-
mation. Another conditional mode is to switch between them
for different types of peptides according to preset parameters
(e.g. different charge states and m/z). In 2008, a data dependent
decision tree (ddDT) algorithm was developed to automati-
cally determine if CID or ETD should be utilized to fragment a
speciﬁc precursor. It was tested on Saccharomyces cerevisiae and
human cells with an improved sequencing success rate and
more  identiﬁcations [99,107]. Therefore these different mass
spectrometric approaches showed complementary capabili-
ties in expanding the crustacean neuropeptidome coverage,
which is greater than any single instrument could reach.
3.2.  Structural  determination  of  larger  NPs
MS  based studies on crustacean NPs generally focus on small
peptides with a sequence of ∼20 amino acids. Yet there is still
a portion of larger peptides, namely the crustacean hyper-
glycemic hormone (CHH) precursor-related peptide (CPRP)
(30+ aa) and the CHH family peptides (70+ aa), including CHH,
molt-inhibiting hormone (MIH), vitellogenesis-inhibiting hor-
mone (VIH) and mandibular organ-inhibiting hormone
(MOIH). CHH may have several isoforms in one or more
neurosecretory organs such as the sinus glands (SG), the
stomatogastric nervous system (STNS) and the pericardial
organs (PO) [108] regulating many  physiological processes,
such as energy homeostasis involving blood glucose level and
metabolism of lipids, reproduction, molting [109]. However,
because of their large size which results in inefﬁcient frag-
mentation, multiple post-translational modiﬁcations, such
as disulﬁde linkages and N-terminal pyroglutamylation, it is
extremely challenging to de novo sequence peptides from the
CHH family. The very low abundances (usually nM-pM) and
absence of genome information could further complicate this
situation. Previously sequence elucidation of such large pep-
tides was typically done with the help of Edman degradation
[110,111]. Some other efforts trying to sequence them depend
on truncated parts of the full length peptides present in tissue
extract, which are shorter and always come with lower charge
states, and that is what CID could handle [112,113].
The application of ETD greatly facilitates de novo sequenc-
ing of larger peptides like CPRP and CHH. By taking advantage
of ETD, which outperforms CID in fragmenting highly charged
precursors, intact CPRP was fragmented and successfully
sequenced solely by mass spectrometry [42]. In the following
studies concerned with CHH peptide family, ETD (or electron
capture dissociation (ECD)) was used as a so-called ‘top-down’
method to gain sequence information about the intact pep-
tide. While CID works best for small tryptic peptides, it was
employed to solve the sequence from the other direction,
namely ‘bottom-up’. The hybrid combination of ‘top-down’ 3 ( 2 0 1 4 ) 152–170
and ‘bottom-up’ approach was reported to de novo sequence
CHH by Ma et al. for the ﬁrst time [43]. In this work, the
intact CHH was fragmented by collision activated dissociation
(CAD), infrared multiphoton dissociation (IRMPD), and ECD as
multi-pronged MS/MS analysis of CHH. Merging information
together from ‘top-down’ and ‘bottom-up’ approaches made
the attempt to sequence CHH peptide by mass spectrome-
try alone succeed. This workﬂow was further developed by
Jia et al. by including one more  off-line top-down analysis
to achieve increased conﬁdence in determining each residue.
Six CHH-family NPs, including two novel peptides, were fully
sequenced. With the complete sequence information, the
spatial distribution of CHH peptides were mapped and con-
formational changes caused by the N-terminal pyroglutamate
were explored for the ﬁrst time [52].
3.3.  Chemical  derivatization  enhanced  peptide
sequencing  and  identiﬁcation
High quality MS/MS fragmentation is essential to determine
peptide sequences. However, challenges exist due to possible
incompleteness of MS/MS fragmentation or extensive inter-
nal fragmentations. Multiple derivatization reactions have
been introduced to overcome such difﬁculties and resolve
ambiguities in mass spectrometric sequencing, allowing eas-
ier interpretation. These derivatization reactions including
methyl esteriﬁcation, reductive methylation, and acetylation
were utilized to facilitate de novo sequencing and resolve
sequence ambiguities.
Formaldehyde labeling has been developed [114] and later
applied for improved sequencing of the crustacean neuropep-
tidome [104,115,116]. It increases the signals of a/b ion series,
resulting in the conﬁrmation of N-terminal sequence with
the a1 ion, and reduces the complexity of the MS/MS  spectra.
Another advantage lies in that the number of lysine residues
and N-terminal blockage where modiﬁcations in a peptide can
be deduced from mass increments. Fig. 2 shows two exam-
ples of reductive methylation assisted de novo sequencing of
neuropeptides.
N,N-Dimethyl leucine (DiLeu) was reported for the ﬁrst
time by Xiang et al. [117] as an effective labeling reagent,
offering substantially improved peptide b/y fragment ions and
convincing fragment assignments. Additionally, increased
basicity by DiLeu labeling reagents improves ionization efﬁ-
ciency compared to non-derivatized peptides. More  peptides
were observed. DiLeu was therefore employed to assist
sequencing NPs in crustaceans [46,118]. Fig. 3 highlights an
example of improved de novo sequencing and fragmentation
of DiLeu labeled B-type allatostatin neuropeptide.
As aspartic acid and glutamic acid can serve as proton
donators when there is no proton available for fragmenta-
tion or the proton is trapped by arginine, preferential cleavage
adjacent to the acidic amino acid always happen and results
in incomplete fragmentation information. This preferential
cleavage poses challenges in sequencing a peptide [119,120]. C-
terminal derivatization with methyl esteriﬁcation was proven
to improve fragmentation efﬁciency and generate uniform
cleavages along peptide backbones by limiting preferential
cleavage at these acidic residues [121].
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Fig. 2 – ESI-Q-TOF MS/MS  spectra of an A-type AST peptide AGLYSYGLamide (842.461+) before (a) and after (b) reductive
methylation. In panel B, the a-, b-, and y-ion series are labeled according to the MS/MS  of (CH3)2AGLYSYGLamide (870.491+).
(c) ESI-Q-TOF MS/MS  spectra of an A-type AST peptide after reductive methylation (967.511+). No mass shift is observed for
this peptide after the reaction, which indicates the pyroglutamylation (pyr) at the N-terminus.
Adapted with permission from Ref. [14]. Copyright (2009) American Chemical Society.
o
n
o
h
sIn addition to the reactions described above, there are still
ther derivatization strategies reported to be beneﬁcial for de
ovo sequencing, either by reacting with N-terminus [122,123]
r C-terminus [124,125], not yet applied to crustaceans. It is
ighly possible to use them for crustacean neuropeptidomic
tudies.3.4.  Database  searching  and  software  assisted  NP
identiﬁcationTo identify peptides present in a sample, MS/MS  data can be
searched against a sequence database or a database consist-
ing of predicted sequences from an organism’s genome. Since
160  e u  p a o p e n p r o t e o m i c s
Fig. 3 – ESI QTOF MS2 fragmentation (a) before and (b) after
DiLeu labeling of B-type allatostatin NP
(GNWNKFQGSW-NH2).
Adapted with permission from Ref. [117]. Copyright (2010)
American Chemical Society.
of the animals. Comparative distribution and expression levelthere is little known genomic information for crustacean
species, direct de novo sequencing of MS/MS data is often
needed, which follows peak centroiding, charge deconvo-
lution and deisotoping. Sometimes a database exists and
an agreement between database search results and de novo
sequencing can provide cross-validation. Several platforms
are developed to perform de novo sequencing, either man-
ually or automatically. Several examples generally used are
Luteﬁsk ([126], http://www.hairyfatguy.com/luteﬁsk/), PepSeq
(packaged with Waters’ MassLynx software http://www.
waters.com), PepNovo ([127], http://proteomics.ucsd.edu/
Software/PepNovo.html), Mascot Distiller (http://www.
matrixscience.com/distiller.html), and PEAKS ([55],
http://www.bioinfor.com/peaks/features/denovo.html), and
there is still increasing interest in developing new algorithms
in recent years [128–131]. De novo sequencing greatly helps
with interpreting MS/MS  data, but it is hard to ignore sequenc-
ing errors that might occur due to, for example, isobaric effect
or low mass accuracy. The candidate sequences generated
by de novo sequencing can then be evaluated for homology
with previously known peptides via BLAST homology search
(http://www.ncbi.nlm.nih.gov/BLAST/). Homology search
may provide an evolutionary view concerning the peptide of
interest among different species. BLAST still does not con-
sider de novo sequencing errors that might cause sequence
mismatches. As one step ahead, SPIDER, MEME and OpenSea
use optimized methods which are more  tolerant to de novo
sequencing errors than BLAST and this feature makes them
generate correct sequences more  easily [132–134]. In addition
to comparing proteins or peptides between species, it is
now possible to use peptides from one species to search
against an expressed sequence tag (EST) database of another
species of interest, predicting putative peptides encoding
ESTs which could be leads for further mass spectrometric
validations. It has been effective in discovering NPs even 3 ( 2 0 1 4 ) 152–170
though the crustacean genome has not fully been sequenced
[44,135].
4.  Distribution  analysis  by  MS  imaging
The functions of different NPs are highly related to their local-
izations. The application of MALDI MSI, ﬁrst demonstrated
by Caprioli [136,137], greatly facilitates the localization of NPs
in an entire tissue slices. Mass spectra are acquired accord-
ing to a predeﬁned grid across the sample while a coordinate
system is superimposed on the tissue. After a series of spec-
tra is collected, hundreds of ions can be assigned to different
coordinates, therefore relating their identities and potential
functions to locations.
Our group pioneered in the MSI characterization of crus-
tacean using various MS platforms on different species. The
goal of the MSI  studies is to reveal the relationship between
the biological function and the location of biomolecules, such
as lipids, NPs and proteins. DeKeyser et al. [17] found more
than 30 NPs from 10 different families using MALDI-TOF/TOF
MS instrument to perform MSI study on both pericardial organ
(PO) and brain of the Jonah crab, Cancer borealis. Selected NPs
were also in situ fragmented via post-source decay (PSD) and
collisional-induced dissociation (CID) to conﬁdently charac-
terize their identities. NPs from the same family presented
similar spatial localization respectively while several excep-
tions existed in RFamide-family and orcokinin-family. This
study also reported the relative distribution of NP families and
provided useful insights into the positive correlation between
biological location and function. For example, NPs from AST-
A and AST-B family were known to have inhibitory effects
on the pyloric rhythm in the stomach [138,139]. Despite the
unique chemical structures of these two NP families, MSI
study showed remarkable overlapping of their localization.
Chen et al. [140] mapped the distribution of several major NP
families in the brain of the lobster Homarus americanus using
both MALDI TOF/TOF and MALDI LTQ Orbitrap MS. The lat-
ter platform provided high mass resolution and accuracy for
the detection of NPs with unambiguous assignment of the
ion signals. By combining the distribution information from
MSI and previous biological understanding of the structure
of nervous system, potential functional roles of these NPs
were elucidated. MSI results showed that both CabTRP 1a and
Val-SIFamide were highly concentrated in olfactory lobe (OL)
and accessory lobe (AL) of the brain. While OL and AL are
the two most important neuropils in the olfactory system of
lobster [141], the ﬁnding suggested the potential regulatory
roles of CabTRP 1a and Val-SIFamide in the olfactory system.
Orcokinins were localized in the area of antenna II neuropil
(AnN) and lateral antennular neuropil (LAN) with higher sig-
nal intensities, suggesting their function in the tactile sensory.
Another tachykinin-related novel NP CalsTRP was detected in
a different crustacean system, C. sapidus, by Hui et al. [142] MSI
study from MALDI TOF/TOF suggested the colocalization of
CalsTRP with the previously identiﬁed CabTRP 1a in the brainstudies were performed between fed and unfed animals. The
up-regulation and colocalization of both CabTRP 1a and Cal-
sTRP indicated the same preprotachykinin they were encoded
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Fig. 4 – Reconstructed 3D images of the distribution of (a) CabTRP 1a and (b) lipid PC 38:6 in the brain of Cancer borealis by
MALDI MSI  using (a) regular matrix coating and (b) dry matrix spraying which favors the detection of lipids.
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y and supported their functions in the gastric mill and pyloric
hythm.
For a complex tissue like the brain of crustacean, 2D MS
maging is not sufﬁcient to represent the global distribution of
io-functional compounds inside its heterogeneous structure
onsisting of various neuropils and neuronal clusters. Chen
t al. [18] were able to build up a 3D map  of NP distribution in
he brain of a Cancer borealis using 2D information from serial
ections. More  than 20 NPs from 8 families were reconstructed
hroughout the brain. A comparison of the 3D distribution
etween NPs and phospholipids reﬂected their distinct local-
zation pattern as shown in Fig. 4. Findings from this study
rovided another dimension beyond 2D MSI to display more
n-depth information of the molecular distribution in crus-
acean tissue. Readers are referred to a more  comprehensive
eview of 3D MSI  for detailed development in the area [143].
As a result of the development of instrumentation,
esearchers were able to look into neuronal structures that
re complex yet with minute size. Ye et al. [31] studied the
istribution of NPs in the stomatogastric nervous system of C.
apidus using both MALDI TOF/TOF and MALDI FT-ICR, where
he former platform provides high spatial resolution and the
atter provides high mass spectral resolution.
With these sensitive, accurate and high-throughput plat-
orms, it was possible to unambiguously discover novel NPs
nd map  their biological distribution at trace level simul-
aneously. In this study, 55 NPs from 10 families were
haracterized from major ganglia in C. sapidus stomatogas-
ric nervous system for the ﬁrst time. Representative results
f the localization of NPs inside the stomatogastric ganglion
STG) were shown in Fig. 5. Their comprehensive distribution
hroughout the ganglia and connecting nerves provided useful
nsights about potential biological functions as well.
.  Quantitation  of  NPsnother aspect in determining NP functions is to assess
heir quantitative information in response to a physiological
hange.5.1.  Crustacean  NP  MS  quantitation
The crustacean nervous system has long served as an excel-
lent model system for novel NP discovery and neuronal
regulation of physiological studies. A key advantage of using
the crustacean model system is that the role of speciﬁc NPs in
neuromodulation can be assessed at the neural circuit and sin-
gle cell level. Accurate and reliable quantitative measurement
of NPs in different biological samples is an important way to
help address functionality related questions [144]. Reviews by
Keller [8] and Christie et al. [3] nicely summarized different
crustacean NP families, including their general structures, and
their bioactivities.
However, most MS-based quantitation strategies are for
protein level quantitation, which can be categorized into label-
free and stable-isotope-labeling approaches, where absolute
or relative quantitation could be accomplished upon different
demands. Despite the rapid growth in protein quantitation
strategies, quantitative studies on crustacean NPs, on the
other hand, still need to be further explored.
The study on quantitation of crustacean NPs is very limited.
Our lab has established a multi-faceted mass spectrometry-
based platform to study crustacean NPs, and has contributed
several successful methodologies and generated new infor-
mation about neuropeptide families and their organization
[43,44,52,90,113,115,117,121]. Isotopic formaldehyde labeling
has been used in NP quantitation by N-terminal dimethylation
or dimethylation of the lysine side-chain. It has been proven to
enhance peptide fragmentation with the production of inten-
sive immonium ions after tandem mass fragmentation by Fu
and Li [145]. By labeling NPs with light or heavy formaldehyde,
a 28 Da or 32 Da mass shift will be generated. The 4 Da mass
difference between light and heavy labeled peptides allows
the direct comparison of same peptide in different samples.
Hui et al. [146] used this method to identify a novel feeding
related tachykinin-related peptide. Wang and co-workers also
measured the salinity stress induced NP changes in two  crab
species using formaldehyde labeling coupled with capillary
electrophoresis (CE)-MS [118].
Another in-house developed isobaric labeling strategy,
DiLeu, by Xiang et al. [117], allows the simultaneous
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Fig. 5 – Representative MSI  results of the NPs distributions in Callinectes sapidus STG by MALDI TOF/TOF. (a) An optical
image of the STG subjected to subsequent IMS  preparation. Nine NPs form ﬁve different families were  shown above.
AST-Bs: (b) AGWSSMRGAWa (m/z 1107.52), (c) SGDWSSLRGAWa (m/z 1220.58), and (d) VPNDWAHFRGSWa (m/z 1470.70).
SIFamide: SIFamide GYRKPPFNGSIFa (m/z 1381.74). RFamides: (f) NRNFLRFa (m/z 965.54), (g) SQPSKNYLRFa (m/z 1238.66), and
(h) pQDLDHVFLRFa (m/z 1271.64). CabTRP 1a: APSGFLGMRa (m/z 934.49). Orcokinin: NFDEIDRSSFGFN (m/z 1547.68). For
comparison, the distribution of (k) a lipid PC (38:6) (m/z 806.57) is shown. (l) is an overlaid image of (c), (h), and (k), displayed
in green, red, and blue, respectively. (For interpretation of the references to color in this ﬁgure legend, the reader is referred
to the web version of this article.)
Adapted with permission from Ref. [31].
comparison of 4 biological samples with comparable if not bet-
ter performance comparing with the commercially available
isobaric tag, iTRAQ, with a much reduced cost per experiment.
It has been proven to provide accurate and reliable quantita-
tive comparison in proteomic studies, as shown by Jiang et al.
[89] in the study of neuropeptidomic expression changes in
the stamotagastric ganglion at multiple development stages
of the lobster H. americanus.
Label-free quantitative strategies can also be used in crus-
tacean NP studies. The chromatographic peak area [147,148]
or ion intensity can be used to represent the concentrations of
corresponding peptides. The assumption behind this strategy
is that the concentration of the peptide of interest is linearly
proportional to the area under the curve (AUC) measured.
Schmerberg and Li [70] have characterized the concentration
changes of 7 NPs upon feeding by comparing the correspond-
ing area under the curve of extracted ion chromatogram in
Jonah crabs, Cancer borealis. An internal standard was added
to normalize the possible instrumental variations.Reproducible and accurate measurements of analytes
across different samples could be tricky for various reasons.
Despite the variation in biological samples, some technical
variations need to be taken into careful consideration. Onlythe same peptide-ion pairs could be compared between dif-
ferent samples, which are assigned based on retention time
and mass accuracy. Not only could the retention time and
mass accuracy be variable among different LC–MS/MS runs,
but other factors such as signal intensity and background
interference could affect the accuracy of quantitative compar-
ison [149,150]. Different data normalization strategies could be
applied to improve quantitation accuracy.
Spectral counting [151,152] is another well-established
label-free quantitative strategy for relative quantitation. It is
based on the observation that the more  abundant the pro-
tein, the more  abundant its peptides, which could generate
more  MS/MS spectra upon fragmentation. As demonstrated by
Liu et al. [153], spectral counting exhibited a good linear cor-
relation within the dynamic range of 2 orders of magnitude
in yeast. One disadvantage is the suppression of lower abun-
dance proteins from high abundance proteins, which could
lead to poor performance for low-abundance proteins.
Since Mann and co-workers [154] described the protein
quantitation using SILAC, it has been a popular quantitative
proteomics technique. The incorporation of isotopes relies on
providing isotopically labeled essential amino acids in growth
media. Recently, NeuCode SILAC, described by the Coon group
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155,156], was shown to reduce precursor ion interference on
he MS1 level and allow high-plexed protein quantitation.
Stable isotopic labeling strategies allow simultaneous com-
arison of multiple samples by introducing a mass difference
ag to the protein or peptide. The labeled proteins/peptides
ill exhibit the same or similar chromatographic characteris-
ics with unlabeled samples. In general, different tags would
ave similar composition: a reporter group, a balance group
nd a reactive group [157,158]. Each reporter has its unique
/z, where the balance group is designed to balance out the
ass difference between each reporter and reactive group
nd aids the labeling reaction after which it gets cleaved. The
ame labeled peptide across different samples will have the
ame mass shift. The quantitative comparison can be realized
fter MS/MS  fragmentation when each speciﬁc reporter gets
xposed and detected with the mass analyzer. Quantitation is
chieved at the MS/MS  level.
Isotope Coded Afﬁnity Tag (ICAT), introduced by Gygi and
ebersold in 1999 [159], was cysteine speciﬁc with two differ-
nt forms of reporter groups which are 8 Da apart. In 2003, a
ewer version of ICAT, cICAT was developed to reduce the deu-
erium effect and to resolve the possible confusion caused by
ouble labeling or oxidation [160,161].
The original 4-plex isobaric Tags for Relative and Abso-
ute Quantiﬁcation (iTRAQ) technique was published in 2004
y Ross et al. [162]. The advantages of iTRAQ over ICAT are
s follows. First, iTRAQ has an amine-reactive group which
argets the N-terminus of peptide or protein, so it has a
ider application range than ICAT. Second, it overcomes the
imitation of binary quantiﬁcation by offering multiplexing
apability. Being one of the only two commercially available
sobaric labeling tags, iTRAQ gains its popularity quickly and
as shown its value in multiple areas. Now with 8-plex iTRAQ
163,164], the capability and analytical throughput of such iso-
opic tags has been improved greatly.
Mass differential Tags for Relative and Absolute Quantiﬁ-
ation (mTRAQ) is a new amine-reactive labeling tag, which
s an extension of the iTRAQ technique. After labeling, for
rginine C-terminated peptides, precursor mass will shift 0,
 and 8 Da, respectively. For C-terminal lysine peptides, 0, 8
nd 16 Da mass difference will be generated. It is designed
or biomarker validation serving as an alternative strategy to
sotopic synthetic peptide standards in MRM  assays [165–167].
Tandem mass tags (TMT) are commercially available from
hermo Scientiﬁc; two-plex and six-plex sets are available.
odo-TMT is also available for targeting cysteine containing
roteins/peptides. These quantitation methods can be readily
xtended to neuropeptide quantitation with the exception
hat Iodo-TMT would have limited utility only for Cys-
ontaining NPs.
.2.  Isobaric  labeling  quantitation  on  MS3 level
n isobaric labeling strategy, interference from co-
ragmentation of targeted-peptide and neighboring isobaric
ons could compromise the accuracy and precision of quanti-
ation results [168–170]. Recently, Ting et al. [171] reported on
liminating interference at the MS3 level where an additional
solation and fragmentation event was performed. Another
as-phase puriﬁcation strategy described by Wenger et al. ( 2 0 1 4 ) 152–170 163
[172] could remove interfering ions with different charge
states by integrating proton-transfer ion–ion reactions (PTR).
However, the cost with these methods is the data acquisition
speed and sensitivity due to sample loss at every fragmen-
tation event. Another method to minimize interference and
quantify sample difference at the MS2 level was proposed
by Wuhr et al. [173] using isotopic labeling tag fragment ion
clusters instead of reporters. Although more  accurate quan-
titation could be achieved with this method, fragmentation
efﬁciency is still a big concern.
5.3.  Neutron-encoded  labels
Developed by Herbert et al. [174], neutron-encoded labeling
technique quantiﬁes proteins by taking advantage of high
resolution and high mass accuracy mass spectrometers. It
is based on the subtle mass differences in neutron-binding
energy between stable isotopes and allows high-plex MS1 level
proteomic quantitation. NeuCode has been combined with
SILAC and also been incorporated in a novel set of amine-
reactive chemical labeling tags [155,156,175]. NeuCode based
methods, however, require the use of mass spectrometer with
a resolving power of more  than 200,000 because the mass dif-
ference generated by NeuCode tags is only at mDa  level.
5.4.  Data-independent  acquisition  (DIA)
In a typical MS/MS experiment, where data-dependent acqui-
sition (DDA) is often utilized, precursor ion survey scans (MS)
and top N most intensive fragment ions scans (MS/MS) are
cycled to result in a ﬁnal chromatogram. The balance between
MS  and MS/MS scans need to be optimized in order to achieve
maximal peptide identiﬁcations and better quantitation accu-
racy. Alternatively, data-independent acquisition (DIA) could
be utilized, where all ions are fragmented without choosing
speciﬁc precursor ions. DIA has been available in multiple
instruments and gained its popularity in quantitative studies.
This has been termed as MSE in Waters Q-TOF instrument,
which works by alternating low and high collision energies,
while in Thermo Orbitraps, it is named as all-ion fragmenta-
tion (AIF), and SWATH in AB ScieX instruments.
5.5.  MRM  based  quantitation
Quantitation of targeted analytes with an isotopically labeled
analog as internal standard has been used in LC–MS since 1987
[176,177]. With advances in mass spectrometry, selected reac-
tion monitoring (SRM) or multiple reactions monitoring (MRM)
based quantiﬁcation technology became the gold standard in
targeted quantitative proteomic studies. Speciﬁc peptides for
targeted protein quantiﬁcation were selected for fragmenta-
tion after protein digestion was carried out. Characteristic b-
and y-ions were generated in MS/MS analysis for the peptide,
respectively. The intact peptide ion (precursor) and its spe-
ciﬁc b-/y-ion pairs are called transitions. MRM  experiments
monitor such selected transitions and compare parallel with
corresponding ion pairs from the isotopically labeled analog
to give speciﬁc and highly sensitive quantitative information.
Spiked-in isotopic peptide standards could help differenti-
ate targeted peptides from background interference and offer
 m i c s
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more  accurate quantitative information. Targeted peptides
would co-elute with heavy peptide analogs, and share simi-
lar fragmentation pattern with a mass shift in precursor and
fragment ions. Such mass difference can conﬁrm the identity
of targeted peptides, especially when other co-eluting transi-
tions exist.
The key step for a successful MRM  quantitation assay is
the selection of target peptides. Prior knowledge of proteins of
interest is required for such selection. The selected peptides
have to be unique for the proteins of interest and proven to
be detectable by MS/MS  from previous experiments. Peptide
fragmentation conditions need to be optimized to ensure the
performance of the assay. Transitions can be selected based
on previous studies, predicted fragments from computational
simulation, or analysis of synthetic peptide standards.
Introduced ﬁrstly by Gygi et al. [178] in 2003, MRM based
techniques have been applied in absolute quantitation (AQUA)
of proteins. The protein’s concentration is determined by mea-
suring its corresponding tryptic peptide concentrations. In
this method, absolute quantitation is reached by adding a
known amount of isotopically labeled peptide standard into
the sample to monitor the quantity changes. Numerous pro-
tein quantitation studies [179] have been published based on
the general AQUA protocol [180].
One limitation with the triple quadrupole instruments
is the low resolution measurements in which interference
may become a major concern for complex mixtures. A new
targeted proteomics quantitation strategy, parallel reaction
monitoring (PRM), is proposed to restrict interference based
on using a newer high resolution quadrupole-Orbitrap hybrid
MS platform [181,182]. It allows the parallel identiﬁcation and
quantiﬁcation of proteins by replacing the third quadrupole
in a triple quadrupole instrument with a high resolution, high
mass accuracy orbitrap mass analyzer. Preliminary results
suggest that PRM could provide comparable quantitative per-
formance to MRM  assays on triple quadrupole instruments,
yet offers fast scanning and high resolution mass spectra to
aid in speciﬁcally extracting signals of targeted peptides.
6.  Summary
The ﬁeld of peptidomics has gone far beyond just peptide
identiﬁcation. The ability to accurately and reliably mea-
sure changing protein/peptide concentrations in biological
samples under different conditions is in high demand. The
development of quantitation techniques could help address
important biological questions. Both label-free and isotopic
labeling approaches have been widely utilized to achieve abso-
lute or relative quantitation and their performances have been
compared [183].
The label-free approach could bypass the isobaric tags,
which are normally very expensive, and there is no limi-
tation on the number of samples that could be compared.
However, due to the nature of sample handling, and mass
spectrometry instrumentation, variations and interference
are the main obstacles to gain accurate and reproducible
quantitation [184–186]. Isotopic labeling strategies, however,
are often considered more  accurate. Nonetheless, an addi-
tional labeling step is needed and the labeling efﬁciency could 3 ( 2 0 1 4 ) 152–170
be a concern. Due to the availability of isobaric labeling tags,
the number of samples that can be analyzed in one experi-
ment is limited. Some labeling strategies are limited to only
certain types of samples.
Signiﬁcant advances in mass spectrometry instrumenta-
tion and associated methodologies have greatly accelerated
the progress in the ﬁeld of crustacean neuropeptidomics.
More than twenty NP families, with different numbers of
NPs ranging from several to hundreds, have been discovered
and assigned to biological functions. The MS-based technique
possesses high speed, high sensitivity, increasing accuracy
and impressive chemical information at the same time. With
chemical, spatial and temporal information, a more  complete
picture of peptidergic signaling can be generated for various
model organisms under a variety of physiological processes.
However, much development is still needed for every step of
the peptidomics pipeline, ranging from sample preparation,
structural elucidation, to spatial localization and quantitation,
to address the remaining challenges of neuropeptidomic anal-
ysis and to fully understand the diverse roles of NPs. At the
same time, the evolving new generations of MS  instrumenta-
tion and bioinformatics tools are also expected to propel the
advancement of this highly dynamic and rapidly growing ﬁeld
of research.
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